Blood test may replace painful bone marrow biopsy for rare cancer monitoring
NCT ID NCT03952052
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study looked at 45 people newly diagnosed with Waldenström's disease, a rare blood cancer. Researchers compared different methods to detect a common genetic mutation (MYD88 L265P) in blood and bone marrow samples. The goal was to see if a simple blood test could replace invasive bone marrow biopsies for tracking the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Henri Becquerel
Rouen, 76000, France
Conditions
Explore the condition pages connected to this study.